Gilead unveils pediatric drug development center in Ireland with 33 new jobs

Gilead Sciences has unveiled a new global pediatric drug development center in Ireland that will have 33 job openings by the end of 2022.

Gilead, with operations in more than 35 countries and headquarters in California, is opening the center in Dublin—its first Global Centre of Excellence for Pediatric Clinical Trials outside the U.S. The center will focus on the development of new pediatric formulations for its portfolio of medicines, with more than 30 new job postings slated for 2022, according to an April 6 announcement.